reported low or absent CHK2 expression in non-small-cell lung carcinomas to result from hypermethylation of the CHK2 gene promoter, leading to subsequent silencing of CHK2 gene transcription (67). This evidence concerns the gene CHEK2 and non-small cell lung carcinoma.